- 1. MYALGIA AND MYOSITIS NOS
- (UMLS (ICD9CM) C0026893) =Disease or Syndrome
| - 51. mycosis chemotherapy
- [ ] (UMLS (CSP) C0872224) =Therapeutic or Preventive Procedure ;
|
- 2. Myambutol
- (UMLS (NCI) C0026895) =Organic Chemical; Pharmacologic Substance ;
| - 52. Mycosis Fungoides (Working Formulation)
- [(mye-KO-sis fun-GOY-deez) ( NCI )] (UMLS (NCI) C0862195) =Neoplastic Process
|
- 3. myasthenia gravis
- [disease characterized by progressive weakness and exhaustibility of voluntary muscles without atrophy or sensory disturbance and caused by an autoimmune attack on acetylcholine receptors at the neuromuscular junction. ( CSP )] (UMLS (CSP) C0026896) =Disease or Syndrome =autoimmune disease;
myoneural disorder;
Autoimmune Diseases of the Nervous System;
Neuromuscular Junction Diseases =Myasthenia Gravis, Neonatal;
Myasthenia Gravis, Experimental Autoimmune;
| - 53. MYCOSIS FUNGOIDES ABDOM
- (UMLS (ICD9CM) C0153804) =Neoplastic Process
|
- 4. Myasthenia gravis with (acute) exacerbation
- [ ] (UMLS (ICD9CM) C1260411) MYASTHNA GRAVS W AC EXAC =Disease or Syndrome
| - 54. Mycosis Fungoides and Sezary Syndrome
- [Mature T and NK neoplasms predominantly affecting the skin and the peripheral blood. Peripheral blood involvement by abnormal T-cells (cerebriform cells) is a late manifestation of mycosis fungoides, whereas it is the presenting finding in Sezary syndrome. —2003 ( NCI )] (UMLS (NCI) C0862196) =Neoplastic Process
|
- 5. Myasthenia gravis without (acute) exacerbation
- [ ] (UMLS (ICD9CM) C1260409) MYSTHNA GRVS W/O AC EXAC =Disease or Syndrome
| - 55. MYCOSIS FUNGOIDES AXILLA
- [ ] (UMLS (ICD9CM) C0153805) =Neoplastic Process
|
- 6. MYASTHENIA IN OTH DIS
- (UMLS (ICD9CM) C0026897) =Disease or Syndrome
| - 56. MYCOSIS FUNGOIDES HEAD
- (UMLS (ICD9CM) C0153802) =Neoplastic Process
|
- 7. MYB Binding Protein (p160) 1A
- [Widely expressed as a 4.5-kb transcript by human MYBBP1A Gene, 1328-aa 149-kDa MYB Binding Protein 1A contains a central acidic region, C-terminal basic amino acid repeats, and potential leucine charged domain motifs throughout. MYBBP1A shares approximately 80% amino acid sequence similarity with the mouse and rat Mybbp1a homolog, a ubiquitous nucleolar protein that specifically interacts with leucine zipper motifs in the MYB negative regulatory domain (NRD) to modulate MYB hemopoietic cell proliferation and differentiation activity. Disruption of the MYB NRD leucine zipper motif, increases MYB DNA binding, transactivation, and transformation. (NCI) ( NCI )] (UMLS (NCI) C0670878) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 57. MYCOSIS FUNGOIDES INGUIN
- [ ] (UMLS (ICD9CM) C0153806) =Neoplastic Process
|
- 8. MYB Binding Protein (P160) 1A Gene
- [This gene plays a role both as an activator and repressor of transcription. ( NCI )] (UMLS (NCI) C1334537) MYBBP1A;
MYBBP1A Gene =Gene or Genome | - 58. Mycosis fungoides involving intrapelvic lymph nodes
- [ ] (UMLS (ICD9CM) C0153807) =Neoplastic Process
|
- 9. Myb Oncogene Protein
- [Human MYB Oncogene Protein is a product of a mutated variant (Oncogene MYB) of MYB Gene, which encodes 6 alternative isoforms of 640 aa 72-kDa nuclear c-MYB protein, a DNA-binding transcriptional activator critical for hematopoietic progenitor cell proliferation and differentiation. MYB contains 3 N-terminal MYB-like DNA-binding domains that specifically recognize YAAC[GT]G, a central transcriptional activation domain and a C-terminal transcriptional repression domain. MYB may interact with HIPK2 and NLK; phosphorylation by NLK on multiple sites may induce proteasomal degradation. Ubiquitination may be mediated by SIAH1. MYB Oncogene Protein disrupts normal cell function. ( NCI )] (UMLS (NCI) C0069529) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 59. Mycosis fungoides involving intrathoracic lymph nodes
- (UMLS (ICD9CM) C0153803) =Neoplastic Process
|
- 10. MYBL1
- [This gene plays a role in transcriptional regulation and cellular differentiation. ( NCI )] (UMLS (NCI) C0812292) MYBL1 Gene;
v-MYB Myeloblastosis Viral Oncogene Homolog (Avian)-Like 1 Gene;
=Gene or Genome | - 60. Mycosis fungoides involving lymph nodes of multiple sites
- [ ] (UMLS (ICD9CM) C0153809) =Neoplastic Process
|
- 11. MYBL2
- [This gene plays a regulatory role in cell cycle progression. ( NCI )] (UMLS (NCI) C0812291) MYBL2 Gene;
v-MYB Myeloblastosis Viral Oncogene Homolog (Avian)-Like 2 Gene;
=Gene or Genome | - 61. Mycosis fungoides involving spleen
- [ ] (UMLS (ICD9CM) C0153808) =Neoplastic Process
|
- 12. MYC Family Gene
- [MYC Family Genes encode MYC Family Proteins, class III bHLH leucine zipper transcription factors having cellular proliferative and apoptotic roles. Dimerization via leucine zippers of MYC proteins with bHLH/lz proteins, such as MAX, is required for efficient DNA binding. Leucine zippers are present in many gene regulatory proteins, including CREB proteins, Jun/AP1 transcription factors, and FOS-type proteins, as well as MYC proteins. The periodically repeated leucine side chains extending from one alpha helix interdigitate with leucine residues of another alpha helix, facilitating coiled-coil dimerization; like charge repulsion in this region perturbs homodimer formation; heterodimers are promoted by opposing charge attractions. c-MYC transcription factor binds to CAC(GA)TG DNA sites. MYC sequences have been highly conserved throughout evolution, from Drosophila to vertebrates. (NCI) ( NCI )] (UMLS (NCI) C0026902) =Gene or Genome
| - 62. Mycosis Fungoides Recurrent
- (UMLS (NCI) C0854849) Mycosis Fungoides Relapsed;
Recurrent Mycosis Fungoides;
Relapsed Mycosis Fungoides =Neoplastic Process |
- 13. MYC Family Protein
- [MYC family proteins exhibit sequence homology with the transcription factor MYC protooncogene. ( NCI )] (UMLS (NCI) C0919474) MYC Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 63. Mycosis Fungoides Refractory
- [Mycosis fungoides resistant to treatment ( NCI )] (UMLS (NCI) C0854850) Refractory Mycosis Fungoides;
=Neoplastic Process |
- 14. MYC Related Gene From Lung Cancer
- [This gene is involved in transcriptional regulation and is frequently amplified in small-cell lung cancer. ( NCI )] (UMLS (NCI) C0812289) MYCL;
MYCL1 Gene;
Oncogene LMYC;
v-MYC Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (Avian) Gene;
=Gene or Genome | - 64. Mycosis Fungoides Stage I
- (UMLS (NCI) C0278567) =Neoplastic Process
|
- 15. MYC-Family Oncogene
- [Variants of proto-oncogenes that are members of the MYC family of early response genes, which encode regulatory proteins that act as homo- or hetero-dimers. These aberrant genes are activated by mutations or amplification, resulting in overexpression of the protein products. This can cause uncontrolled cell proliferation. ( NCI )] (UMLS (NCI) C0919472) =Gene or Genome ;
| - 65. Mycosis Fungoides Stage II
- (UMLS (NCI) C0278569) =Neoplastic Process
|
- 16. Mycelex
- (UMLS (NCI) C0699671) =Organic Chemical; Pharmacologic Substance
| - 66. Mycosis Fungoides Stage III
- (UMLS (NCI) C0278571) =Neoplastic Process
|
- 17. Mycelex Troche
- (UMLS (NCI) C0306874) =Clinical Drug ;
| - 67. Mycosis fungoides, unspecified site, extranodal and solid organ sites
- (UMLS (ICD9CM) C0375088) =Neoplastic Process
|
- 18. mycelium
- [The body of a fungus which is made up of HYPHAE. ( MSH )] (UMLS (CSP) C0949695) =Fungus ;
| - 68. mycostatin
- (UMLS (NCI) C0699477) =Organic Chemical; Antibiotic
|
- 19. Mycetozoa
- [ ] (UMLS (CSP) C1069250) =Invertebrate ;
| - 69. Mycotic Aneurysm
- (UMLS (NCI) C0085808) =Disease or Syndrome ;
|
- 20. MYCN
- [This gene is involved in transcriptional regulation and amplification of this gene is associated with a variety of tumors, most notably neuroblastomas. ( NCI )] (UMLS (NCI) C0812287) MYCN Gene;
Neuroblastoma MYC Oncogene;
N-MYC;
Oncogene MYCN;
Oncogene NMYC;
v-MYC Myelocytomatosis Viral Related Oncogene, Neuroblastoma Derived (Avian);
v-MYC Myelocytomatosis Viral Related Oncogene, Neuroblastoma Derived (Avian) Gene =Gene or Genome | - 70. MYCOTIC CORNEAL ULCER
- [ ] (UMLS (ICD9CM) C0155071) =Disease or Syndrome ;
|
- 21. MYCN Protein
- [The MYCN oncogene is amplified in approximately 25% of neuroblastoma tumors and is the most significant negative prognostic factor. In neuroblastoma, the MYCN oncogene directly activates genes required for DNA replication, and this may contribute to neoplastic transformation of these MYCN-amplified tumors. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. (from PMID 11861392 and NCI) ( NCI )] (UMLS (NCI) C0079885) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 71. Mydriasis (persistent), not due to mydriatics
- (UMLS (ICD9CM) C0026962) =Pathologic Function
|
- 22. MYCNOS
- [This gene plays a role in the transcriptional activation of target genes. ( NCI )] (UMLS (NCI) C1424629) MYCNOS Gene;
V-Myc Myelocytomatosis Viral Related Oncogene, Neuroblastoma Derived (Avian) Opposite Strand Gene =Gene or Genome | - 72. mydriatic
- [Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. The latter cause cycloplegia or paralysis of accommodation at high doses and may precipitate glaucoma. Mydriatics are used in eye diseases and to facilitate eye examination. ( MSH )] (UMLS (CSP) C0026964) =Pharmacologic Substance
|
- 23. MYCOBACTERIAL DIS NEC
- [ ] (UMLS (ICD9CM) C0152951) =Disease or Syndrome
| - 73. mydriatic/cycloplegic
- [agents that dilate the pupil of the eye. ( CSP )] (UMLS (CSP) C0357659) =Pharmacologic Substance ;
=[OP000] OPHTHALMIC AGENTS;
|
- 24. MYCOBACTERIAL DIS NOS
- [Infections with bacteria of the genus MYCOBACTERIUM. ( MSH )] (UMLS (ICD9CM) C0026918) =Disease or Syndrome ;
=Actinomycetales infection;
=Hansen's disease;
Mycobacterium Infections, Atypical;
Paratuberculosis;
tuberculosis;
| - 74. Myectomy
- (UMLS (NCI) C0185279) =Therapeutic or Preventive Procedure
|
- 25. Mycobacteriology
- (UMLS (HL7) C1547988) =Intellectual Product =Diagnostic Service Section ID;
| - 75. myelencephalon
- [The most posterior portion of the hindbrain from which MEDULLA OBLONGATA is derived. ( MSH )] (UMLS (CSP) C1959627) =Body Part, Organ, or Organ Component
|
- 26. Mycobacterium
- [genus of gram positive, aerobic bacteria; most species are free living in soil and water, but the major habitat for some is the diseased tissue of warm blooded hosts. ( CSP )] (UMLS (CSP) C0026912) =Bacterium =Actinomycetales;
=Mycobacterium avium;
Mycobacterium bovis;
Mycobacterium leprae;
Mycobacterium tuberculosis;
Mycobacterium intracellulare;
Mycobacterium smegmatis;
| - 76. myelin
- [fatty, axon-enwrapping sheath that serves to speed up neural conduction, formed by concentric layers of Schwann's cell (peripheral) or oligodendrocyte (CNS) membranes; loss or damage leads to severe loss of neural function, as in multiple sclerosis. ( CSP )] (UMLS (NCI) C0026969) =Tissue =Body System, Neurologic;
=Node of Ranvier;
myelination;
|
- 27. Mycobacterium avium
- [bacterium causing tuberculosis in domestic fowl and other birds; in pigs, it may cause localized and sometimes disseminated disease; the organism occurs occasionally in sheep and cattle; it should be distinguished from the M. avium complex, which infects primarily humans. ( CSP )] (UMLS (CSP) C0026913) =Bacterium =Mycobacterium;
| - 77. Myelin
- [The lipid-rich sheath surrounding AXONS in both the central and peripheral nervous systems. The myelin sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial cells (SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the central nervous system). Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem. ( MSH )] (UMLS (NCI) C0026973) =Cell Component
|
- 28. Mycobacterium avium Complex
- [A complex that includes several strains of M. avium. M. intracellulare is not easily distinguished from M. avium and therefore is included in the complex. These organisms are most frequently found in pulmonary secretions from persons with a tuberculous-like mycobacteriosis. Strains of this complex have also been associated with childhood lymphadenitis and AIDS; M. avium alone causes tuberculosis in a variety of birds and other animals, including pigs. ( MSH )] (UMLS (CSP) C0026914) =Bacterium ◊ [A nontuberculous infection when occurring in humans. It is characterized by pulmonary disease, lymphadenitis in children, and systemic disease in AIDS patients. Mycobacterium avium-intracellulare infection of birds and swine results in tuberculosis. ( MSH )] (UMLS (CSP) C0026916) Disease or Syndrome Mycobacterium Infections, Atypical;
| - 78. myelin basic protein
- [positively charged myelin protein believed to be the autoantigen in multiple sclerosis and its animal model, EAE. ( CSP )] (UMLS (CSP) C0014063) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine =nerve/myelin protein;
|
- 29. Mycobacterium bovis
- [bovine variety of the tubercle bacillus; it is called also Mycobacterium tuberculosis var. bovis. ( CSP )] (UMLS (CSP) C0026917) =Bacterium ;
=Mycobacterium;
| - 79. myelin degeneration
- [ ] (UMLS (CSP) C0333456) =Pathologic Function
|
- 30. Mycobacterium intracellulare
- [species found in lung lesions and secretions of humans; may cause bone and tendon-sheath lesions in rabbits; some strains are pathogenic for mice; linked to opportunistic infections in humans; not easily distinguished from Mycobacterium avium and therefore is included in the Mycobacterium avium Complex. ( CSP )] (UMLS (CSP) C0086662) =Bacterium =Mycobacterium;
| - 80. myelin protein
- [Proteins found in the myelin sheath. The major proteins of central nervous system myelin include: MYELIN PROTEOLIPID PROTEIN; MYELIN BASIC PROTEINS; and MYELIN-ASSOCIATED GLYCOPROTEIN. The major proteins of peripheral nervous system myelin include: MYELIN BASIC PROTEINS (myelin P1 protein and MYELIN P2 PROTEIN); MYELIN P0 PROTEIN; and MYELIN-ASSOCIATED GLYCOPROTEIN. ( MSH )] (UMLS (CSP) C0026972) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 31. Mycobacterium leprae
- [species of gram positive, aerobic bacteria that causes leprosy in man; its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side. ( CSP )] (UMLS (CSP) C0026922) =Bacterium ;
=Mycobacterium;
| - 81. myelin proteolipid
- [family of fatty acylated, extremely hydrophobic membrane proteins that serve to glue the intracellular faces of myelin lamellae in tight apposition; accounts for more than half of total myelin protein. ( CSP )] (UMLS (CSP) C0060617) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine =proteolipid;
nerve/myelin protein |
- 32. Mycobacterium lepraemurium
- [The etiologic agent of rat leprosy, also known as murine leprosy. ( MSH )] (UMLS (CSP) C0026923) =Bacterium ;
| - 82. Myelinated Nerve Fiber
- [Axons of neurons encased in a lipoproteinaceous material called myelin. (MeSH) ( NCI )] (UMLS (NCI) C0027750) =Cell Component ;
|
- 33. Mycobacterium phlei
- [A saprophytic bacterium widely distributed in soil and dust and on plants. ( MSH )] (UMLS (CSP) C0026924) =Bacterium ;
| - 83. myelination
- [forming of the myelin sheath, the cylindrical covering that insulates the axons of some neurons; formed from the plasma membrane of Schwann cells or oligodendrocytes. ( CSP )] (UMLS (CSP) C0596991) =Cell Function =myelin;
|
- 34. Mycobacterium smegmatis
- [rapid growing, nonphotochromogenic species of mycobacterium originally isolated from human smegma and found also in soil and water. ( CSP )] (UMLS (CSP) C0317761) =Bacterium =Mycobacterium;
| - 84. myelinopathy
- [disease or destruction of myelin, the myelin sheath, or the white matter of the brain. ( CSP )] (UMLS (CSP) C0596992) =Disease or Syndrome =Central Nervous System Disease;
=autoimmune encephalomyelitis;
cerebrotendinous xanthomatosis;
Marchiafava Bignami disease;
telencephalic leukoencephalopathy;
viral myelinopathy;
|
- 35. Mycobacterium tuberculosis
- [species of gram positive, aerobic bacteria that produces tuberculosis in man, other primates, dogs, and some animals which have contact with man; growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. ( CSP )] (UMLS (CSP) C0026926) =Bacterium ;
=Mycobacterium;
| - 85. myelitis
- [Inflammation of the spinal cord. Relatively common etiologies include infections; AUTOIMMUNE DISEASES; SPINAL CORD; and ischemia (see also SPINAL CORD VASCULAR DISEASES). Clinical features generally include weakness, sensory loss, localized pain, incontinence, and other signs of autonomic dysfunction. ( MSH )] (UMLS (CSP) C0026975) =Disease or Syndrome =myelopathy;
Central Nervous System Viral Diseases =Myelitis, Transverse;
Paraparesis, Tropical Spastic;
Acute Poliomyelitis |
- 36. Mycobutin
- (UMLS (NCI) C0733659) =Organic Chemical; Antibiotic ;
| - 86. MYELITIS CAUSE NEC
- [ ] (UMLS (ICD9CM) C1719367) Other causes of myelitis =Disease or Syndrome ;
|
- 37. mycolate
- [ ] (UMLS (CSP) C0598634) =Lipid ;
| - 87. MYELITIS D/T OTH INFECT
- [ ] (UMLS (ICD9CM) C1719351) Other myelitis due to infection classified elsewhere =Disease or Syndrome
|
- 38. mycolic acid
- [ ] (UMLS (CSP) C0026931) =Lipid; Biologically Active Substance
| - 88. Myelitis following immunization procedures
- [ ] (UMLS (ICD9CM) C1719356) MYELITIS FOLLWG IMMUNE =Disease or Syndrome ;
|
- 39. Mycology
- (UMLS (HL7) C1561961) =Intellectual Product =Diagnostic Service Section ID;
| - 89. Myelitis in viral diseases classified elsewhere
- [ ] (UMLS (ICD9CM) C1719347) MYELITIS-OTH VIRAL DIS =Disease or Syndrome
|
- 40. mycolysin
- [ ] (UMLS (CSP) C0075303) =Amino Acid, Peptide, or Protein; Enzyme ;
=metalloendopeptidase;
| - 90. Myeloablative Agonist
- [Agents that destroy bone marrow activity. They are used to prepare patients for BONE MARROW TRANSPLANTATION or STEM CELL TRANSPLANTATION. ( MSH )] (UMLS (NCI) C0524867) =Pharmacologic Substance ;
|
- 41. Mycophenolate
- [The morpholinoethyl ester of mycophenolic acid (MPA). As an immunosuppressive agent in vivo, the active metabolite mycophenolate reversibly inhibits inosine 5'-monophosphate dehydrogenase (IMPDH), an enzyme involved in the de novo synthesis of guanine nucleotides, thereby retarding T-cell and B-cell proliferation. MPA displays high lymphocyte specificity and cytotoxicity because lymphocyte metabolism is highly dependent on both salvage and de novo synthesis of guanine nucleotides. (NCI04) ( NCI )] (UMLS (NCI) C0883242) MYCOPHENOLATE PREPARATION =Organic Chemical; Pharmacologic Substance =[IM600] IMMUNE SUPPRESSANTS;
RS 61443 =MMF;
| - 91. Myeloblast
- [An immature cell that represents the first stage in the granulocytic series of hematopoiesis. It is found in bone marrow and differentiates into a promyelocyte. Its nucleus is composed of very fine, evenly distributed chromatin with 2-5 nucleoli. The cytoplasm is basophilic and non-granular. ( NCI )] (UMLS (NCI) C0229633) =Cell ;
|
- 42. Mycophenolate Mofetil Hydrochloride
- (UMLS (NCI) C0772450) =Organic Chemical; Pharmacologic Substance ;
| - 92. Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1334838) Myeloblasts Between 10 and 19 Percent of Bone Marrow Nucleated Cells;
Myeloblasts Between 10 and 19% of Bone Marrow Nucleated Cells =Laboratory or Test Result ;
|
- 43. Mycophenolate Sodium
- (UMLS (NCI) C1337395) =Lipid; Antibiotic
| - 93. Myeloblasts 10-19 Percent of Peripheral Blood White Cells
- (UMLS (NCI) C1334839) Myeloblasts Between 10 and 19% of Peripheral Blood White Cells;
=Laboratory or Test Result |
- 44. Mycoplasma
- [genus of gram negative, mostly facultatively anaerobic bacteria in the family Mycoplasmataceae; the cells are bounded by a plasma membrane and lack a true cell wall; its organisms are pathogens found on the mucous membranes of humans, animals, and birds. ( CSP )] (UMLS (CSP) C0026934) =Bacterium ;
=Mycoplasmatales;
=Eaton Liu agent;
Mycoplasma genitalium;
| - 94. Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells
- (UMLS (NCI) C1334840) Myeloblasts 20% or More of Bone Marrow Non-Erythroid Cells;
=Laboratory or Test Result |
- 45. MYCOPLASMA
- [ ] (UMLS (ICD9CM) C0374992) =Disease or Syndrome
| - 95. Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1334841) Myeloblasts 20% or More of Bone Marrow Nucleated Cells;
=Laboratory or Test Result |
- 46. Mycoplasma fermentans
- [A species of the genus MYCOPLASMA, originally isolated infrequently from the lower genital tract of humans, and possessing uncertain pathogenicity. The incognitus strain of M. fermentans has been identified in necrotizing lesions of multiple organs from AIDS and non-AIDS patients dying of an acute influenza-like disease. ( MSH )] (UMLS (CSP) C0085384) =Bacterium
| - 96. Myeloblasts 20 Percent or More of Peripheral Blood White Cells
- (UMLS (NCI) C1334842) Myeloblasts 20% or More of Peripheral Blood White Cells;
=Laboratory or Test Result |
- 47. Mycoplasma genitalium
- [species of gram negative bacteria originally isolated from urethral specimens of patients with non-gonoccocal urethritis; in primates it exists in parasitic association with ciliated epithelial cells in the genital and respiratory tracts. ( CSP )] (UMLS (CSP) C0317872) =Bacterium =Mycoplasma;
| - 97. Myeloblasts 5-19 Percent of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1334843) Myeloblasts 5-19% of Bone Marrow Nucleated Cells;
=Laboratory or Test Result |
- 48. Mycoplasma hominis
- [A common inhabitant of the vagina and cervix and a potential human pathogen, causing infections of the male and female reproductive tracts. It has also been associated with respiratory disease and pharyngitis. (From Dorland, 28th ed) ( MSH )] (UMLS (CSP) C0317838) =Bacterium
| - 98. Myeloblasts 5-19 Percent of Peripheral Blood White Cells
- (UMLS (NCI) C1334844) Myeloblasts 5-19% of Peripheral Blood White Cells;
=Laboratory or Test Result |
- 49. Mycoplasmatales
- [order of highly pleomorphic, gram negative bacteria including both pathogenic and saprophytic species. ( CSP )] (UMLS (CSP) C0026944) =Bacterium ;
=bacteria;
=Mycoplasma | - 99. Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1334845) Myeloblasts 5-9% of Bone Marrow Nucleated Cells;
=Laboratory or Test Result |
- 50. MYCOSES NEC & NOS
- [ ] (UMLS (ICD9CM) C0029511) =Disease or Syndrome
| - 100. Myeloblasts Under 1 Percent of Peripheral Blood White Cells
- (UMLS (NCI) C1334847) Myeloblasts Under 1% of Peripheral Blood White Cells;
=Laboratory or Test Result |
home
